Keyword: GSK

News

GSK’s Consumer Health Flotation Flags

21.07.2022 -

The Jul.18 launch of GSK’s consumer healthcare spinoff Haleon on the London Stock Exchange – said to be the largest London listing in more than a decade – seems to have...

Reserach & Innovation

New Covid Shots Score Points against Omicron

27.06.2022 -

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.

Chemistry & Life Sciences

Where Science Meets Business

19.04.2022 -

From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.

News

Sanofi/GSK and Moderna Seal Vaccine Supply in Canada

24.09.2020 -

Both the Sanofi/GlaxoSmithKline partnership and US vaccine producer Moderna this week announced new advance purchase agreements with Canada for their Covid-19 vaccine...

News

Sanofi and GSK Ink EU Vaccine Deal

22.09.2020 -

Sanofi and GSK have agreed a deal with the EU to supply up to 300 million doses of their recombinant protein-based Covd-19 vaccine pending regulatory approval, which is...

News

Sanofi and GSK Seal Vaccine Deals with US and UK

03.08.2020 -

Lagging behind other big names of late in announcing Covid-19 vaccine supply deals, French and British drugmakers Sanofi and GlaxoSmithkline together nailed down...

News

GSK to Make Adjuvants for Several Covid Vaccines

05.06.2020 - GlaxoSmithKline (GSK) has agreed to make 1 billion doses of its AS03 adjuvant available to several developers of Covid-19 vaccines and plans to increase capacity to supply enough...

News

GSK in Manufacturing Pact with Samsung Biologics

25.05.2020 - GlaxoSmithKline has agreed an eight-year, $231 million, pact with South Korean CDMO Samsung Biologics to scale up manufacturing of biologics. The capacity Samsung provides will be...